Literature DB >> 1636672

Protein kinase C affects microfilaments, bone resorption, and [Ca2+]o sensing in cultured osteoclasts.

A Teti1, S Colucci, M Grano, L Argentino, A Zambonin Zallone.   

Abstract

The effects of protein kinase C (PKC) in the control of osteoclast activity are still unknown. We investigated the role of the enzyme in the control of microfilament organization, podosome assembly, bone resorption, and extracellular Ca2+ sensing in chicken and rabbit osteoclasts treated with agents known to affect PKC activity. Cells were treated for 20 min with a PKC activator [phorbol 12-myristate 13-acetate (PMA)], a PKC inhibitor (staurosporine), a protein kinase A (PKA) inhibitor (H-9), a guanosine 3',5'-cyclic monophosphate-dependent protein kinase-PKA-PKC inhibitor (H-7), or with the inactive phorbol, 4 alpha-phorbol, to examine microfilaments by decoration with rhodamine-phalloidin. In PMA-treated osteoclasts, the number of microfilament-containing adhesion structures (podosomes) per cell decreased. However, enlarged microfilamentous cores in podosomes and stress fiber-like filaments, otherwise absent in controls, appeared. Whereas H-7 induced increase of the number of podosomes, staurosporine, H-9, and 4 alpha-phorbol failed to change microfilament organization. Chicken osteoclasts received also long-term treatment with the agents in the presence of [3H]proline-prelabeled chicken or rat bone particles to measure bone resorption. PMA, as well as staurosporine and H-7, stimulated the resorbing activity, whereas cells were insensitive to H-9 and 4 alpha-phorbol. Measurement of cytosolic free calcium concentration in PMA-treated fura-2-loaded single osteoclasts demonstrated a synergistic effect of PKC activation on the inhibitory extracellular calcium concentration-sensing mechanism, which was, by contrast, blocked by H-7, staurosporine, and H-9 and was insensitive to 4 alpha-phorbol. These results indicate that PKC regulates osteoclast activity inducing both morphological and functional modifications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1636672     DOI: 10.1152/ajpcell.1992.263.1.C130

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

Review 2.  Adhesions ring: a structural comparison between podosomes and the immune synapse.

Authors:  Sarah A Wernimont; Christa L Cortesio; William T N Simonson; Anna Huttenlocher
Journal:  Eur J Cell Biol       Date:  2008-03-17       Impact factor: 4.492

Review 3.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

4.  The protein kinase C cascade regulates recruitment of matrix metalloprotease 9 to podosomes and its release and activation.

Authors:  Helan Xiao; Xiao-Hui Bai; Andras Kapus; Wei-Yang Lu; Alan S Mak; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2010-10-11       Impact factor: 4.272

Review 5.  The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2016-08-30       Impact factor: 3.396

6.  Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.

Authors:  S M Goicoechea; R García-Mata; J Staub; A Valdivia; L Sharek; C G McCulloch; R F Hwang; R Urrutia; J J Yeh; H J Kim; C A Otey
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

7.  Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption.

Authors:  Mette G Sørensen; Morten A Karsdal; Morten H Dziegiel; Jean A Boutin; Olivier Nosjean; Kim Henriksen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

8.  Effect of diacylglycerols on osteoclastic bone resorption.

Authors:  B S Moonga; L S Stein; J M Kilb; D W Dempster
Journal:  Calcif Tissue Int       Date:  1996-08       Impact factor: 4.333

9.  Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A.

Authors:  Hiroshi Kajiya; Fujio Okamoto; Hidefumi Fukushima; Koji Okabe
Journal:  Pflugers Arch       Date:  2003-01-14       Impact factor: 3.657

10.  Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro.

Authors:  M Yamaguchi; Z J Ma
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.